• Research, Science, and Trials

  Have you heard of this groundbreaking research update?

  Posted by ChristinaC on October 8, 2025 at 9:20 am

  There has been recent and positive data showing that Nomlabofusp can lead to an increase in frataxin levels for people with Friedreich’s ataxia over time. In addition, this will slow down the disease progression.

  How do you feel about this potential disease-modifying therapy?

  For more information on this press release, please click below:

  https://friedreichsataxianews.com/news/nomlabofusp-leads-long-term-frataxin-gains-fa-patients-extension-study/

  ChristinaC replied 5 months, 3 weeks ago 1 Member · 0 Replies

  • Nomlabofusp
  • research
  • research update
• 0 Replies

Log In to Reply